Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.
2.

Highly Reproducible 16S Sequencing Facilitates Measurement of Host Genetic Influences on the Stickleback Gut Microbiome.

Small CM, Currey M, Beck EA, Bassham S, Cresko WA.

mSystems. 2019 Aug 13;4(4). pii: e00331-19. doi: 10.1128/mSystems.00331-19.

3.
4.

Gene flow between Drosophila yakuba and Drosophila santomea in subunit V of cytochrome c oxidase: A potential case of cytonuclear cointrogression.

Beck EA, Thompson AC, Sharbrough J, Brud E, Llopart A.

Evolution. 2015 Aug;69(8):1973-86. doi: 10.1111/evo.12718. Epub 2015 Aug 8.

5.

Subnormal plasma von Willebrand factor (ristocetin cofactor) and iron deficiency anaemia in menstruating women.

Beck EA, Limoni C.

Thromb Haemost. 1996 Apr;75(4):693. No abstract available.

PMID:
8743201
6.

Fibrinogen Claro--another dysfunctional fibrinogen variant with gamma 275 arginine-->histidine substitution.

Steinmann C, Jungo M, Beck EA, Lämmle B, Furlan M.

Thromb Res. 1996 Jan 1;81(1):145-50. No abstract available. Erratum in: Thromb Res 1996 Apr 1;82(1):107.

PMID:
8747529
7.

Thrombohemorrhagic phenomena associated with infectious diseases.

Beck EA, Dejana E.

Semin Hematol. 1988 Apr;25(2):91-100. Review. No abstract available.

PMID:
3291132
8.

[A modified in vivo platelet retention test in the evaluation of primary hemostasis].

de la Cuadra JL, Jeanneret C, Furlan M, Beck EA.

Schweiz Med Wochenschr. 1987 Nov 14;117(46):1814-6. German.

PMID:
3423768
9.

Monitoring of heparin therapy with the activated partial thromboplastin time and chromogenic substrate assays.

Fey MF, Lang M, Furlan M, Beck EA.

Thromb Haemost. 1987 Oct 28;58(3):853-5.

PMID:
3481140
10.

[Blood coagulation disorders].

Beck EA.

Schweiz Med Wochenschr. 1987 May 2;117(18):682-7. German.

PMID:
3109027
11.

Exposure of platelet binding sites in von Willebrand factor by adsorption onto polystyrene latex particles.

Furlan M, Stieger J, Beck EA.

Biochim Biophys Acta. 1987 Apr 16;924(1):27-37.

PMID:
3493809
12.

Fibrinogen Bergamo III and fibrinogen Torino: two further variants with hereditary molecular defects in fibrinopeptide A.

Reber P, Furlan M, Beck EA, Barbui T.

Thromb Res. 1987 Apr 1;46(1):163-7. No abstract available.

PMID:
3590111
13.

[Hemostatic disorders. The therapeutic consequences for oral surgical treatment].

Ilgenstein B, Berthold H, Beck EA.

Schweiz Monatsschr Zahnmed. 1987;97(4):473-7. German. No abstract available.

PMID:
3296171
14.

Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.

Reber P, Furlan M, Henschen A, Kaudewitz H, Barbui T, Hilgard P, Nenci GG, Berrettini M, Beck EA.

Thromb Haemost. 1986 Dec 15;56(3):401-6.

PMID:
3563970
15.

[Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].

Lang M, Fey MF, Furlan M, Beck EA.

Schweiz Med Wochenschr. 1986 Nov 29;116(48):1681-4. German.

PMID:
3798064
16.

[Binding of the von Willebrand factor to solid surfaces: effect of shear strength].

Furlan M, Beck EA.

Schweiz Med Wochenschr. 1986 Oct 25;116(43):1490-2. German.

PMID:
3097818
17.

[A new test for evaluating the von Willebrand factor: collagen-induced agglutination of fixed thrombocytes].

Stieger J, de la Cuadra J, Furlan M, Beck EA.

Schweiz Med Wochenschr. 1986 Oct 25;116(43):1489-90. German.

PMID:
3097817
18.
19.

Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization.

Reber P, Furlan M, Rupp C, Kehl M, Henschen A, Mannucci PM, Beck EA.

Blood. 1986 Jun;67(6):1751-6.

PMID:
3708159
20.
21.

[How can we improve long-term anticoagulation?].

Beck EA.

Schweiz Med Wochenschr. 1985 Oct 26;115(43):1495-500. German.

PMID:
4081678
22.

[From Quick's percentage to the INR (International Normalized Ratio)--a real advance in the control of oral anticoagulation].

Beck EA.

Schweiz Med Wochenschr. 1985 Oct 5;115(40):1378-80. German. No abstract available.

PMID:
4071012
23.

[Effect of psychological factors on the course and symptoms of a genetically determined disease as exemplified by hemophilia].

Bärtschi E, Beck EA.

Psychother Psychosom Med Psychol. 1985 Oct-Nov;35(10-11):290-4. German. No abstract available.

PMID:
4070530
24.
25.
26.

Factors influencing hydrocarbon degradation in three freshwater lakes.

Cooney JJ, Silver SA, Beck EA.

Microb Ecol. 1985 Jun;11(2):127-37. doi: 10.1007/BF02010485.

PMID:
24221301
27.

Inhibition of human T lymphocyte proliferation in vitro by commercial factor VIII concentrates.

Wang Y, Beck EA, Furlan M, de Weck AL.

Vox Sang. 1985;48(6):343-9.

PMID:
3925631
28.

Pelvic and acetabular fractures: examination by angled CT scanning.

Burk DL Jr, Mears DC, Herbert DL, Straub WH, Cooperstein LA, Beck EA.

Radiology. 1984 Nov;153(2):548.

PMID:
6484188
29.

[Desamino-8-D-arginine vasopressin nose drops in the treatment of mild hemophilia A and von Willebrand's disease].

Streit A, Furlan M, Beck EA.

Schweiz Med Wochenschr. 1984 Oct 6;114(40):1389-91. German.

PMID:
6333722
30.

Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.

Dejana E, Furlan M, Barbieri B, Donati MB, Beck EA.

Thromb Haemost. 1984 Aug 31;52(1):57-9.

PMID:
6437011
31.

Isolation of small molecular forms of Factor VIII/von Willebrand factor from plasma.

Perret BA, Furlan M, Beck EA.

Haemostasis. 1984;14(4):289-95.

PMID:
6437941
32.

Congenital dysfibrinogenemia.

Rupp C, Beck EA.

Curr Probl Clin Biochem. 1984;14:65-130. Review. No abstract available.

PMID:
6150812
33.

Surface of factor VIII/von Willebrand factor in solution: studies with dye-sensitized photochemical labelling.

Furlan M, Stalder M, Perret BA, Beck EA.

Thromb Res. 1983 Nov 1;32(3):343-9. No abstract available.

PMID:
6419381
35.
36.

[Hemostasis disorders with reduced activity of the von Willebrand factor in myeloproliferative syndromes].

Leupin L, Beck EA, Furlan M, Bucher U.

Schweiz Med Wochenschr. 1983 May 14;113(19):713-6. German.

PMID:
6603016
37.

Silver staining of high molecular weight proteins on large-pore polyacrylamide gels.

Perret BA, Felix R, Furlan M, Beck EA.

Anal Biochem. 1983 May;131(1):46-50.

PMID:
6193732
38.

Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.

Furlan M, Rupp C, Beck EA.

Biochim Biophys Acta. 1983 Jan 12;742(1):25-32.

PMID:
6824684
39.

Effect of calcium and synthetic peptides on fibrin polymerization.

Furlan M, Rupp C, Beck EA, Svendsen L.

Thromb Haemost. 1982 Apr 30;47(2):118-21.

PMID:
7101230
40.

[The 5q syndrome--a chromosome aberration with characteristic hematologic picture: preleukemia? Literature review and description of a personal case].

Mueller RA, Auf der Maur P, Beck EA, Deubelbeiss K, Bucher U.

Schweiz Med Wochenschr. 1982 Feb 13;112(7):242-52. German.

PMID:
7071578
41.

Binding of bovine factor VIII-coated colloidal gold particles to receptors on platelet membranes.

Perret BA, Furlan M, Beck EA.

Agents Actions. 1981 Dec;11(6-7):657-9.

PMID:
6803540
42.

[Fibrinogen Bern I and fibrinogen Bern II: 2 hereditary fibrinogen variants with diverse biochemical properties].

Rupp C, Kuyas C, Haeberli A, Furlan M, von Fliedner V, Beck EA.

Schweiz Med Wochenschr. 1981 Oct 10;111(41):1543-5. German.

PMID:
7313627
43.

Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.

Furlan M, Perret BA, Beck EA.

Thromb Haemost. 1981 Jun 30;45(3):242-6.

PMID:
6792738
44.

Fractionation of individual, biologically active factor VIII multimers.

Perret BA, Furlan M, Kneubuehl F, Beck EA.

Biochim Biophys Acta. 1981 Jun 29;669(1):98-104.

PMID:
6794637
45.

Binding of colloidal gold granules, coated with bovine factor VIII, to human platelet membranes.

Furlan M, Horisberger M, Perret BA, Beck EA.

Br J Haematol. 1981 Jun;48(2):319-24.

PMID:
6786321
46.

Factor VIII activity in chronic renal disease.

Wegmüller E, Grüninger U, Furlan M, Beck EA, Hodler J, Reubi FC.

Nephron. 1981;28(4):157-62.

PMID:
6795517
47.

[Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].

Furlan M, Perret BA, Beck EA.

Schweiz Med Wochenschr. 1980 Oct 4;110(40):1456-8. German.

PMID:
6792697
48.

Cryoprotection of human bone marrow committed stem cells (CFU-c) by dextran, glycerol and dimethyl sulfoxide.

Odavic R, Blom J, Beck EA, Bucher U.

Experientia. 1980 Sep 15;36(9):1122-4.

PMID:
6968277
49.

[Normal reference values in frequently carried out laboratory analyses hematologic cytology and blood coagulation)].

Käch O, Sturzenegger MH, Zbinden MA, Bucher U, Beck EA.

Schweiz Med Wochenschr. 1980 Aug 23;110(34):1244-9. German.

PMID:
7423169
50.

Supplemental Content

Support Center